Therapies of mucopolysaccharidosis IVA (Morquio A syndrome)-Reference-Cited by-同舟云学术

Therapies of mucopolysaccharidosis IVA (Morquio A syndrome)

Published:2013-10 Issue:10 Volume:1 Page:805-818
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Tomatsu Shunji,Alméciga-Díaz Carlos J,Barbosa Hector,Montaño Adriana M,Barrera Luis A,Shimada Tsutomu,Yasuda Eriko,Mackenzie William G,Mason Robert W,Suzuki Yasuyuki,Orii Kenji E,Orii Tadao

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://www.tandfonline.com/doi/pdf/10.1517/21678707.2013.846853

Reference106 articles.

1. Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease

2. Development of MPS IVA mouse (Galnstm(hC79S·mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase

3. Murine model (Galnstm(C76S)slu) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins

4. International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Gait Pattern and Lower Extremity Kinematics of Children with Morquio Syndrome (MPS IV);Diagnostics;2021-07-27

2. Evaluation of HIV–1 derived lentiviral vectors as transductors of Mucopolysaccharidosis type IV a fibroblasts;Gene;2021-05

3. Pulmonary Manifestations of Endocrine and Metabolic Diseases in Children;Pediatric Clinics of North America;2021-02

4. Quantification of Finger Laxity in Skeletal Dysplasia;Journal of Clinical Engineering;2021-01

5. Has resveratrol a potential for mucopolysaccharidosis treatment?;European Journal of Pharmacology;2020-12